Clinical nodal staging of T1-2 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation

Cancer Journal

Volumn 16, Issue 3, 2010, Pages 284-287

  Shoushtari, Asal N ^a   Meeneghan, Mathew ^a   Treharne, Gregory C ^a   Reibel, James F ^a   Levine, Paul A ^a   Moskaluk, Christopher A ^b   Jameson, Mark J ^a   Read, Paul W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Human papillomavirus; Ipsilateral cervical radiation for tonsillar cancer; Oropharyngeal squamous cell carcinoma; P16; T1 and T2 tonsillar cancer

Indexed keywords

PROTEIN P16;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; METASTASIS; PRIORITY JOURNAL; SOFT PALATE CANCER; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; TONSILLAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953646508     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181ddd088     Document Type: Article

References (24)

1. Jackson SM, Hay JH, Flores AD, et al. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol. 1999;51:123-128.
2. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol. 2006;29:290-297.
3. O'Sullivan B, Warde P, Grice B, et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 2001;51:332-343.
4. Rusthoven KE, Raben D, Schneider C, et al. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for nodepositive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys. 2009;74:1365-1370.
5. Lim YC, Lee SY, Lim J, et al. Management of contralateral N0 neck in tonsillar squamous cell carcinoma. Laryngoscope. 2005;115:1672-1675.
6. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620-2623.
7. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity modulated radiation therapy (IMRT) outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer. In press.
8. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731-1738.
9. Kim S, Koo B, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR, and c-myc during tumor formation. Int J Cancer. 2007;120:1418-1425.
10. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
11. Lassen P, Eriksen JG, Hamilton-Dutoit S, et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992-1998.
12. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813-1820.
13. Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin N Am. 2008;22:1125-1142.
14. Shonka D, Shoushtari A, Thomas CY, et al. Predicting residual neck disease tion therapy: utility of P16 status. Arch Otolaryngol Head Neck Surg. 2009;135:1126-1132.
15. Hoffmann M, Gorogh T, Gottschlich S, et al. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett. 2005;218:199-206. (Pubitemid 40164721)
16. Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys. 1998;42:1077-1084.
17. Murthy A, Hendrickson F. Is contralateral neck treatment necessary in early carcinoma of the tonsil? Int J Radiat Oncol Biol Phys. 1980;6:91-94.
18. Callejo G, Beltran D, Ramos B, et al. Use of imaging criteria to identify cervical metastases using CT scans in head and neck tumours. Acta Otorrinolaringol Esp. 2008;59:257-262.
19. Xu W, Liu D, Lu Z. CT scanning of the cervical lymph node metastases: compared with histologic sections. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1998;12:99-102.
20. Kresnik E, Mikosch P, Gallowitsch HJ, et al. Evaluation of head and neck cancer with 18-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001;28:816-821.
21. Greene F, Page D, Fleming I, et al. American Joint Committee on Cancer: AJCC Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
22. Cardinale FD, Fischer JJ. Radiation therapy of carcinoma of the tonsillar region. Cancer. 1977;39:604-608.
23. Weller SA, Goffinet DR, Goode RL, et al. Carcinoma of the oropharynx. Am J Roentgenol. 1976;126:236-247.
24. Martinez I, Wang J, Hobson KF, et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 2007;43:415-432.